Evidence map›Paper›PMID 35350506›Full record

ArticleCureus2022

Warfarin-Related Nephropathy Manifested as Diffuse Mesangial Proliferative Glomerulonephritis.

Frederick Acquah, Nagapratap Ganta, Dina Alnabwani, Cecily Alaan, Priya Anantharaman, Pramil Cheriyath

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Frederick AcquahInternal Medicine, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Nagapratap GantaInternal Medicine, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Dina AlnabwaniInternal Medicine, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Cecily AlaanInternal Medicine, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Priya AnantharamanNephrology, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Pramil CheriyathInternal Medicine, Hackensack Meridian Health, Ocean University Medical Center, Brick, USA.
Hackensack Meridian Health · USUniversity Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Warfarin is associated with anticoagulant-related nephropathy (ARN), one of the potential side effects. This is evidenced by a progressively increasing number of detected cases of deterioration in the kidney function even in patients with normal baseline function (GFR {glomerular filtration rate}) in addition to the chronic kidney disease (CKD) patients who are already vulnerable to ARN. There has been a clinical correlation in a rapid decline of kidney function and international normalized ratio (INR) levels of greater than three. ARN is a significant but underdiagnosed complication of anticoagulation that is associated with increased renal morbidity and all-cause mortality. We want to emphasize the importance of monitoring kidney function regularly and adjusting the appropriate doses of warfarin. We present a case of a 57-year-old female who was on warfarin for the mechanical aortic valve, presented with acute kidney injury and supratherapeutic INR. Her renal biopsy showed diffuse mesangial proliferative glomerulonephritis.

Indexed as

acute kidney injuryanticoagulant related nephropathychronic kidney diseasediffuse mesangial proliferative glomerulonephritissupratherapeutic inrwarfarin related nephropathy

Identifiers

PMID35350506
PMCPMC8933143
OpenAlexW4213289664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.